Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets.
about
Pharmacometabolomics reveals racial differences in response to atenolol treatmentApplications of metabolomics in cancer researchLivestock metabolomics and the livestock metabolome: A systematic review.Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism.Long term conservation of human metabolic phenotypes and link to heritability.Metabolomics identifies a biological response to chronic low-dose natural uranium contamination in urine samples.Profile of Circulatory Metabolites in a Relapsing-remitting Animal Model of Multiple Sclerosis using Global Metabolomics.Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer.Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer's disease from normal cognitive aging.Responsible healthcare innovation: anticipatory governance of nanodiagnostics for theranostics medicine.Pharmacometabonomics and personalized medicine.Metabolomics applications in precision medicine: An oncological perspective.Omics for Understanding the Gut-Liver-Microbiome Axis and Precision Medicine.The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics.American Ginseng Attenuates Colitis-Associated Colon Carcinogenesis in Mice: Impact on Gut Microbiota and Metabolomics.System pharmacogenomics application in infectious diseases.Chemotherapy-induced gastrointestinal toxicity is associated with changes in serum and urine metabolome and fecal microbiota in male Sprague-Dawley rats.Evaluation of endogenous metabolic markers of hepatic CYP3A activity using metabolic profiling and midazolam clearance.Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.
P2860
Q21559685-EC121643-4DEC-40BA-AF4C-BEF51EECFF28Q24600728-79E27BEF-DD62-47A7-8037-5C65EB00F5DCQ30491739-94142625-4DDC-454A-A5EE-399B104D43CAQ33729425-8B4DFF63-4E0B-446E-B819-3DAE4676153BQ34091261-51B69563-49AB-468E-9D6F-25AE188243A4Q37302454-3A0D6651-3E2B-456B-A8A5-E81BCEF7A5ABQ37334196-C4239E38-47E2-4F9D-8936-50E8684EC1C1Q37457684-886CC2FD-E9A7-4BDE-B567-252D9CC7B410Q37485378-9F0F2F62-E6DE-4D4B-845D-C58F4F8EDE7BQ38068224-65FBBB55-528D-47E5-BDAE-7A61618F687FQ38124254-678C84CD-3516-402E-B325-4F2EB1486C04Q38689857-0E1E83F1-86E7-43FF-80F0-D0D113527929Q38750137-119043EE-F545-40C4-B9E1-5C347E1D47A9Q39249688-F6FFD150-4CEE-4366-9830-091CA8CA632FQ39574717-3A48BA4D-091D-4AE7-ACCE-4E9701DC6513Q40267857-79020C05-D775-42A6-9BBD-97F3EBEE9559Q41160069-BAFF52DB-C3E3-42AE-958E-8070D1ECC667Q46495913-9CB83B4B-8A60-43C0-838D-982C7C99A996Q52666367-2BD9201E-C25C-4B18-A2E1-BDC3CE8EF133
P2860
Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Pharmaco-metabolomics: an emer ...... valuable therapeutic targets.
@ast
Pharmaco-metabolomics: an emer ...... valuable therapeutic targets.
@en
Pharmaco-metabolomics: an emer ...... valuable therapeutic targets.
@nl
type
label
Pharmaco-metabolomics: an emer ...... valuable therapeutic targets.
@ast
Pharmaco-metabolomics: an emer ...... valuable therapeutic targets.
@en
Pharmaco-metabolomics: an emer ...... valuable therapeutic targets.
@nl
prefLabel
Pharmaco-metabolomics: an emer ...... valuable therapeutic targets.
@ast
Pharmaco-metabolomics: an emer ...... valuable therapeutic targets.
@en
Pharmaco-metabolomics: an emer ...... valuable therapeutic targets.
@nl
P2860
P356
P1476
Pharmaco-metabolomics: an emer ...... valuable therapeutic targets.
@en
P2093
Flavio Rizzolio
Giuseppe Corona
P2860
P304
P356
10.1002/JCP.24003
P577
2012-07-01T00:00:00Z